Patents by Inventor Davinder Gill

Davinder Gill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunotherapy Regimes Dependent On APOE Status
    Publication number: 20090155256
    Abstract: The invention provides methods of immunotherapy of Alzheimer's and similar diseases in which the regime administered to a patient depends on the ApoE genotype of the patient.
    Type: Application
    Filed: October 17, 2008
    Publication date: June 18, 2009
    Applicants: Wyeth, Elan Pharma International Limited
    Inventors: Ronald Black, Lars Ekman, Ivan Lieberburg, Michael Grundman, James Callaway, Keith M. Gregg, Jack Steven Jacobsen, Davinder Gill, Lioudmila Tchistiakova, Angela Widom
  • IL-13 binding agents
    Patent number: 7501121
    Abstract: Agents (e.g., antibodies and fragments thereof) that bind specifically to IL 13 and modulate the ability of IL-13 to interact with IL-13 receptors and signaling mediators are disclosed.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: March 10, 2009
    Assignee: Wyeth
    Inventors: Lioudmila Tchistiakova, Marion T. Kasaian, Debra D. Donaldson, Xiang-Yang Tan, Davinder Gill, Macy X. Jin, Bruce Jacobson, Samuel J. Goldman, John Knopf, Angela M. Widom
  • Antibodies against human IL-22 and uses therefor
    Publication number: 20070243589
    Abstract: The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22). The antibodies can act as antagonists of IL-22 activity, thereby modulating immune responses in general, and those mediated by IL-22 in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders.
    Type: Application
    Filed: February 20, 2007
    Publication date: October 18, 2007
    Inventors: Davinder Gill, Jing Li, Geertruida Veldman, Lynette Fouser, Viia Valge-Archer, David Lowe, Caroline Russell, Suzanne Cohen, Albert Thom, Ralph Minter
  • ANTI-5T4 ANTIBODIES AND USES THEREOF
    Publication number: 20070231333
    Abstract: Anti-5T4 antibodies, anti-5T4 antibody/drug conjugates, and methods for preparing and using the same.
    Type: Application
    Filed: March 9, 2007
    Publication date: October 4, 2007
    Applicant: Wyeth
    Inventors: Erwin BOGHAERT, Nitin Damle, Philip Hamann, Kiran Khandke, Arthur Kunz, Kimberly Marquette, Lioudmila Tchistiakova, Davinder Gill, Kodangattil Sreekumar
  • Anti-TrkB monoclonal antibodies and uses thereof
    Publication number: 20070059304
    Abstract: The present invention provides monoclonal antibodies for human TrkB. In certain embodiments the inventive antibodies bind and activate human TrkB. In certain embodiments the inventive antibodies are selective for human TrkB in that they do not bind (or activate) human TrkA or human TrkC. In some embodiments the inventive monoclonal antibodies cross-react with murine TrkB. Humanized or veneered versions of the inventive antibodies are also encompassed. Pharmaceutical compositions that comprise inventive antibodies are provided as are methods for preparing the inventive antibodies and methods of using these for treatment, detection or purification purposes.
    Type: Application
    Filed: June 5, 2006
    Publication date: March 15, 2007
    Inventors: Seongeun Cho, Davinder Gill, Xiang Tan, Ming Qian
  • Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates
    Publication number: 20060088522
    Abstract: Chimeric and humanized anti-5T4 antibodies and antibody/drug conjugates and methods for preparing and using the same.
    Type: Application
    Filed: September 9, 2005
    Publication date: April 27, 2006
    Applicant: Wyeth
    Inventors: Erwin Boghaert, Nitin Damle, Davinder Gill, Kimberly Marquette, Lioudmila Tchistiakova, Philip Hamann, Arthur Kunz
  • IL-13 binding agents
    Publication number: 20060073148
    Abstract: Agents (e.g., antibodies and fragments thereof) that bind specifically to IL 13 and modulate the ability of IL-13 to interact with IL-13 receptors and signaling mediators are disclosed.
    Type: Application
    Filed: June 17, 2005
    Publication date: April 6, 2006
    Inventors: Lioudmila Tchistiakova, Marion Kasaian, Debra Donaldson, Xiang-Yang Tan, Davinder Gill, Macy Jin, Bruce Jacobson, Samuel Goldman, John Knopf, Angela Widom